The composition and function of the microbiota in the human gut changes throughout the day, with links to dietary and bathroom habits. The findings may have implications for the design of future probiotic clinical trials.
After successfully completing a Series B financing, Microbiome Therapeutics is gearing up for the launch of a ‘microbiome modulator’ product designed to help balance the microbiome and support healthy metabolism.
Swapping out refined grains for whole grains does not cause significant shifts in our gut microbes or better insulin resistance – but does result in weight loss, lower food intake, and reduced systemic inflammation, say researchers.
New Blackmores CEO Richard Henfrey has pledged that the firm will look to move beyond selling 'bottles of pills', hinting that a more personalised nutrition approach featuring tests and value-added services could be an option.